Register Login

Abiopharma

Home
About
Newsroom
Company List
Events
Automated Tools
Contact

News list

VIIV HLTHCARE

FDA Approval
Nov. 13, 2023, 13:10 UTC

FDA approve DOLUTEGRAVIR SODIUM; LAMIVUDINE

Full text

Register to leave comments
There are no comments here yet...

Search

News categories

Technical Exchange News(11967)

Event(4985)

SEC News(246496)

FDA Approval(10304)

Company Report(721)

Business News(148671)

© Copyright Abiopharma. All Rights Reserved

Designed by Alexey Vershinin